Pharmacopsychiatry 2009; 42(1): 35-36
DOI: 10.1055/s-0028-1083821
Letter

© Georg Thieme Verlag KG Stuttgart · New York

Excessive Talking Triggered by Methylphenidate in a Boy with ADHD

A. Ghanizadeh 1
  • 1Research Center for Psychiatry and Behavioral Sciences, Shiraz University of Medical Sciences, Hafez Hospital, Shiraz, Iran
Further Information

Publication History

received 13.03.2008 revised 13.05.2008

accepted 02.06.2008

Publication Date:
19 January 2009 (online)

There has previously been no report of provocation of excessive talking as an adverse effect of methylphenidate (MPH) in children with ADHD. This is a report of excessive talking after taking methylphenidate in a child with ADHD, diagnosed according to DSM-IV diagnostic criteria using the bFarsi version of KSADS. His mother and nursery teacher reported a significant increase of talking about 45 min after taking medication. They scored hypertalking as 7–9 on a 1–10 visual analogue scale. There were no symptoms of affective or anxiety disorder. Re-challenge was conducted many times and hypertalking reoccurred after every time he took the medication. It is possible that MPH increases verbal output in some ADHD children.

References

  • 1 Attalah MM, Saied MM, Yahya R. et al . Ketamine anesthesia for short transurethral urologic procedures.  Middle East J Anesthesiol. 1993;  12 123-133
  • 2 Biederman J, Faraone SV. Attention-deficit hyperactivity disorder.  Lancet. 2005;  366 237-248
  • 3 Bilder RM, Lieberman JA, Kim Y. et al . Methylphenidate and neuroleptic effects on oral word production in schizophrenia.  Neuropsychiat Neuropsychol Behav Neurol. 1992;  5 262-271
  • 4 Douglas VI. Cognitive control processes in attention-deficit hyperactivity disorder. In: Quay HC, Hogan AE, eds. Handbook of Disruptive Behavior Disorders. Plenum Press, New York 1999: 105-138
  • 5 Ghanizadeh A, Mohammadi MR, Yazdanshenas A. Psychometric properties of the Farsi translation of the Kiddie Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version.  BMC Psychiatry. 2006;  15 10
  • 6 Kim EY, Miklowitz DJ. Childhood mania, attentiondeficit hyperactivity disorder and conduct disorder: a critical review of diagnostic dilemmas.  Bipolar Disord. 2002;  4 215-225
  • 7 O’Driscoll GA, Dépatie L, Holahan AL. et al . Executive functions and methylphenidate response in subtypes of attention-deficit/hyperactivity disorder.  Biol Psychiatry. 2005;  57 1452-1460
  • 8 Pietrzak RH, Mollica CM, Maruff P. et al . Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder.  Neurosci Biobehav Rev. 2006;  30 1225-1245
  • 9 Pliszka SR. The neuropsychopharmacology of attention-deficit/ hyperactivity disorder.  Biol Psychiatry. 2005;  57 1385-1390
  • 10 Shafritz KM, Marchione KE, Gore JC. et al . The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder.  Am J Psychiatry. 2004;  161 1990-1997
  • 11 Szeszko PR, Bilder RM, Dunlop JA. et al . Longitudinal assessment of methylphenidate effects on oral word production and symptoms in first-episode schizophrenia at acute and stabilized phases.  Biol Psychiatry. 1999;  45 680-686

Correspondence

Prof. A. GhanizadehMD 

Department of Psychiatry

Hafez Hospital

Shiraz

Iran

Fax: +98/711/627 93 19

Email: ghanizad@sina.tums.ac.ir

Email: ghanizadeha@hotmail.com

    >